DSM Venturing makes strategic investment in ChromaDex
In the Netherlands, DSM Venturing, the corporate venture arm of Royal DSM has provided equity financing to ChromaDex Corp. ChromaDex describes itself as an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries.
Frank Jaksch, Jr., CEO and co-founder of ChromaDex, commented, “It is with great pride and enthusiasm that we welcome DSM as a strategic investor in ChromaDex. We believe the investment demonstrates their confidence in the future of ChromaDex as well as our unique business model of acquiring and commercializing novel ingredient technologies.” The financial details of the investment were not disclosed.
Category: Fuels
